Ambien vs. Dayvigo
See how Ambien and Dayvigo compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Ambien is FDA-approved only for short-term insomnia, while Dayvigo has 12-month trial data supporting sustained use without rebound insomnia after stopping.
Both drugs are Schedule IV controlled substances with the same FDA warnings for complex sleep behaviors like sleepwalking and next-day impairment.
Ambien enhances GABA activity like older sleep drugs, while Dayvigo blocks orexin receptors through a newer mechanism that shows lower rates of dizziness in trials.
Ambien vs. Dayvigo Drug Summary
Ambien
Ambien (zolpidem) is a non-benzodiazepine sedative-hypnotic that binds GABA-A receptors to help people fall asleep faster. It is FDA-approved for short-term insomnia and is taken as a single tablet once nightly on an empty stomach.
Dayvigo
Dayvigo (lemborexant) is a dual orexin receptor antagonist that blocks wake-promoting brain signals instead of boosting GABA activity. It is FDA-approved for insomnia involving trouble falling asleep, staying asleep, or both, and is taken as one tablet nightly.
Ambien vs. Dayvigo Side Effects
Ambien
Dayvigo
Ambien vs. Dayvigo Dosage
Ambien
Dayvigo
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Ambien
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Dayvigo
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Ambien vs. Dayvigo Indications
Ambien
Ambien is FDA-approved for short-term treatment of insomnia in people who have trouble falling asleep. It is not approved for long-term nightly use or for use in children.
Difficulty falling asleep (sleep-onset insomnia)
Short-term use only, typically a few weeks
Not approved for children
Not approved for chronic nightly use
Dayvigo
Dayvigo is FDA-approved for insomnia in adults who have trouble falling asleep, staying asleep, or both. It is not approved for use in children or for narcolepsy.
Difficulty falling asleep or staying asleep
Supported by 12-month trial data
Not approved for children
Not approved for narcolepsy
Ambien vs. Dayvigo Pros and Cons
Ambien
Ambien has decades of clinical use, a low-cost generic option, and dosing that most prescribers know well. It is only approved for short-term use, and its GABA-based mechanism carries a well-documented next-day impairment risk, especially at the 10 mg dose.
Pros
Inexpensive generic, roughly $15-$90/month without insurance
Long track record since 1992 FDA approval
Faster onset when taken on an empty stomach
Lower starting dose specifically defined for women
Cons
Only approved for short-term insomnia treatment
Higher next-day impairment risk at the 10 mg dose
More reports of dizziness than newer options
No long-term trial data supporting nightly use
Dayvigo
Dayvigo works through a newer orexin-blocking mechanism and has 12-month trial data showing sustained effect without rebound insomnia after stopping. It has no generic version yet, so it costs significantly more out of pocket than Ambien.
Pros
Approved for both falling asleep and staying asleep
12-month data shows no rebound insomnia on stopping
Lower rates of dizziness and next-day drowsiness overall
Different mechanism may help those who don't respond to GABA drugs
Cons
No generic yet, roughly $135-$400/month without insurance
Newer drug with less long-term real-world use
Interacts with CYP3A inhibitors/inducers, limiting drug combinations
Carries a warning for worsening depression or suicidal thoughts
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.